Nintedanib (BIBF1120) is a potent, oral, small-molecule tyrosine kinase inhibitor, also known as a triple angiokinase inhibitor, inhibiting three major signaling pathways involved in angiogenesis.

View the latest Al Rajhi Bank (1120) stock price, news, historical charts, analyst ratings and financial information from WSJ.